سعر ايبوفورم 2000 وحدة دولية فيال 2000 وحدة دولية/1 مل 2022

Recombinant human erythropoietin (epoetin alfa) 2000 IU/1 ml vial for injection (EIPICO).

• Treatment of anemia due to chronic kidney disease (on and not on dialysis), zidovudine in HIV infection, or concomitant myelosuppressive chemotherapy; reduction of allogeneic red blood cell transfusions in elective noncardiac, nonvascular surgery.DailyMed (U.S. NLM)

• Chronic kidney disease: adverse reactions in >=5% included hypertension, arthralgia, muscle spasm, pyrexia, dizziness, medical device malfunction, vascular occlusion and upper respiratory tract infection.General active-ingredient information · DailyMed (U.S. NLM)

• Uncontrolled hypertension; pure red cell aplasia that begins after treatment with an erythropoietin protein drug; serious allergic reactions to the product. (US multiple-dose vials containing benzyl alcohol are additionally contraindicated in neonates, infants, pregnant and lactating women.)General active-ingredient information · DailyMed (U.S. NLM)

• Boxed warning: ESAs increase the risk of death, myocardial infarction, stroke, venous thromboembolism, vascular access thrombosis and tumor progression or recurrence; in CKD, targeting hemoglobin >11 g/dL increased these risks. Use the lowest dose sufficient to reduce red blood cell transfusions.General active-ingredient information · DailyMed (U.S. NLM)

• Limited data in pregnant women are insufficient to determine a drug-associated risk; adverse fetal effects occurred in rats at doses near the recommended starting doses. Use benzyl alcohol-free formulations in pregnancy.General active-ingredient information · DailyMed (U.S. NLM)
• No information on presence in human milk (endogenous erythropoietin is present in milk); benzyl alcohol-containing formulations should not be used in lactating women.General active-ingredient information · DailyMed (U.S. NLM)

• Epoetin alfa: Stimulates erythropoiesis by the same mechanism as endogenous erythropoietin (US Epogen label).